The invention relates to the use of a NK1-/- animal as a model for attention deficit hyperactivity disorder and related conditions, to markers for those conditions and to methods of treating such conditions.

 
Web www.patentalert.com

< FGFR4 ANTIBODIES

< Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists

> Anti-human DLL4 antibodies and compositions

> Antibodies that bind to a member of the IL-6/G-CSF/MGF family
~ 00619